Novel treatment approaches for cutaneous T-cell lymphoma.
Foss
F M
FM
Section of Medical Oncology, University Hospital, Boston, Massachusetts 02118, USA.
Kuzel
T M
TM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D004167:Diphtheria Toxin / Q000627:therapeutic use; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D015851:Interleukin-7 / Q000627:therapeutic use; D016410:Lymphoma, T-Cell, Cutaneous / Q000628:therapy*; D015649:Pentostatin / Q000627:therapeutic use; D012176:Retinoids / Q000627:therapeutic use; D016305:Thymopentin / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; C112050:DAB(389) interleukin-7; D004167:Diphtheria Toxin; D007376:Interleukin-2; D015851:Interleukin-7; D012176:Retinoids; D015649:Pentostatin; D016305:Thymopentin